Low Body Mass Index and Myeloablative Conditioning Regimen Prolong the Duration of Parenteral Nutrition During Hematopoietic Stem Cell Transplantation

Patients undergoing hematopoietic stem cell transplantation (HSCT) often receive total parenteral nutrition (TPN) due to poor oral intake. In clinical practice, it is difficult to predict adequate nutritional management, especially the duration of parenteral nutrition (PN), because of inter-individu...

Full description

Saved in:
Bibliographic Details
Published inAnnals of nutrition and metabolism Vol. 74; no. 2; p. 107
Main Authors Kamiya, Takaki, Hira, Daiki, Hoshino, Nobuo, Kurihara, Mika, Nakagawa, Mayumi, Sasaki, Masaya, Terada, Tomohiro
Format Journal Article
LanguageEnglish
Published Switzerland 01.01.2019
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Patients undergoing hematopoietic stem cell transplantation (HSCT) often receive total parenteral nutrition (TPN) due to poor oral intake. In clinical practice, it is difficult to predict adequate nutritional management, especially the duration of parenteral nutrition (PN), because of inter-individual variability in the conditions and types of treatment regimens. This study investigated the relationship between patient factors and the duration of TPN and the duration of PN. Data on clinical features, patient characteristics, and the duration of TPN and PN were collected from medical records of 61 of 73 patients who underwent HSCT between April 2010 and December 2014 and were analyzed by multiple linear regression analysis. Forty-nine patients (80.3%) received TPN and 53 (86.9%) received PN. Sixty patients were affected by poor oral intake soon after pretreatment. Body mass index (BMI) was significantly correlated with the duration of TPN (β = -2.733; 95% CI -4.679 to -0.787). BMI (β = -2.260; 95% CI -4.304 to -0.213) and conditioning regimen (β = 12.726; 95% CI 0.692-24.76) were significantly correlated with the duration of PN. BMI at admission and the type of conditioning regimen should be considered in choosing the nutritional management plan in patients with HSCT with poor oral intake.
ISSN:1421-9697
DOI:10.1159/000496457